Methods and compositions associated with the granulocyte colony-stimulating factor receptor
申请人:Ligand Pharmaceuticals, Inc.
公开号:US10111859B2
公开(公告)日:2018-10-30
Some embodiments include compositions and methods of using or identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Some embodiments include use of compounds to treat certain disorders, such as hematopoietic or neurological disorders.
一些实施方案包括使用或鉴定调节粒细胞集落刺激因子受体(GCFR)活性的化合物的组合物和方法。一些实施方案包括使用化合物治疗某些疾病,如造血或神经系统疾病。